Accessibility Menu
 
Genus Plc logo

Genus Plc

(LSE) GNS

Current Price$2568.00
Market Cap$171.88B
Since IPO (1998)+2,835%
5 Year-51%
1 Year+59%
1 Month+1%

Genus Plc Financials at a Glance

Market Cap

$171.88B

Revenue (TTM)

$1.34B

Net Income (TTM)

$43.50M

EPS (TTM)

$70.94

P/E Ratio

35.97

Dividend

$32.90

Beta (Volatility)

-0.01 (Low)

Price

$2568.00

Volume

241,415

Open

$2600.00

Previous Close

$2568.00

Daily Range

$2549.90 - $2622.00

52-Week Range

$1558.00 - $3228.80

GNS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genus Plc

Industry

Biotechnology

Employees

3,307

CEO

Jorgen Kokke

Headquarters

Basingstoke, RG21 4DZ, GB

GNS Financials

Key Financial Metrics (TTM)

Gross Margin

1%

Operating Margin

10%

Net Income Margin

7%

Return on Equity

9%

Return on Capital

8%

Return on Assets

5%

Earnings Yield

2.78%

Dividend Yield

0.01%

Payout Ratio

44.42%

Stock Overview

Market Cap

$171.88B

Shares Outstanding

66.41M

Volume

241.41K

Short Interest

0.00%

Avg. Volume

183.77K

Financials (TTM)

Gross Profit

$672.80M

Operating Income

$42.40M

EBITDA

$93.70M

Operating Cash Flow

$67.20M

Capital Expenditure

$18.60M

Free Cash Flow

$48.60M

Cash & ST Invst.

$48.00M

Total Debt

$265.90M

Genus Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$335.60M

+0.6%

Gross Profit

$314.00M

-5.9%

Gross Margin

93.56%

N/A

Market Cap

$171.88B

N/A

Market Cap/Employee

$49.11M

N/A

Employees

3,500

N/A

Net Income

$29.80M

+120.7%

EBITDA

$57.40M

+31.1%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$234.30M

+6.3%

Accounts Receivable

$124.50M

+11.8%

Inventory

$74.20M

-23.2%

Long Term Debt

$263.10M

-3.8%

Short Term Debt

$14.60M

-21.1%

Return on Assets

5.16%

N/A

Return on Invested Capital

8.35%

N/A

Free Cash Flow

$17.60M

+551.3%

Operating Cash Flow

$22.90M

+118.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HCM.LHUTCHMED (China) Limited
$220.50+0.23%
ONT.LOxford Nanopore Technologies plc
$124.50+1.63%
UPR.LUniphar plc
$350.00+0.00%
OXB.LOxford Biomedica plc
$631.00-2.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$57.40-0.01%
ONDSOndas
$10.87+0.01%
OPENOpendoor Technologies
$5.45+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.87-0.03%

Questions About GNS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.